← Eichor
Study identifier: NCT03800017 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Skeletal Muscle Function in Interstitial Lung Disease

Condition: Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis · Hypersensitivity Pneumonitis  ·  Sponsor: University of British Columbia

PhaseNA
Planned participants40
Who can joinAll sexes, 40 Years to 80 Years
Healthy volunteersYes

About this study

Dyspnea (i.e. breathlessness) and exercise intolerance are common symptoms for patients with interstitial lung disease (ILD), yet it is not known why. It has been suggested that muscle dysfunction may contribute to dyspnea and exercise intolerance in ILD. Our study aims to: i) examine differences in the structure and function of the leg muscles in ILD patients, ii) determine if leg muscle fatigue contributes to dyspnea and exercise limitation in patients with ILD, and iii) determine the effects of breathing extra oxygen on leg muscle fatigue, as well as ability to exercise in ILD patients.

This description comes directly from the study's public registry record.

Talk to the study team

Olivia Ferguson, MSc  ·  1-604-806-8835  ·  Olivia.Ferguson@hli.ubc.ca

Satvir S Dhillon, MSc  ·  1-604-806-8835  ·  Satvir.Dhillon@hli.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

St. Paul's HospitalVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03800017